Charles Schwab Investment Management Inc. Boosts Position in BrightSpring Health Services, Inc. $BTSG

Charles Schwab Investment Management Inc. boosted its position in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 9.6% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 494,231 shares of the company’s stock after acquiring an additional 43,238 shares during the quarter. Charles Schwab Investment Management Inc. owned 0.28% of BrightSpring Health Services worth $8,941,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. Wells Fargo & Company MN increased its position in BrightSpring Health Services by 38.7% in the fourth quarter. Wells Fargo & Company MN now owns 63,155 shares of the company’s stock worth $1,076,000 after buying an additional 17,617 shares in the last quarter. Envestnet Asset Management Inc. purchased a new stake in BrightSpring Health Services in the fourth quarter worth about $188,000. First Trust Advisors LP purchased a new stake in BrightSpring Health Services in the fourth quarter worth about $987,000. MetLife Investment Management LLC increased its position in BrightSpring Health Services by 4.9% in the fourth quarter. MetLife Investment Management LLC now owns 33,117 shares of the company’s stock worth $564,000 after buying an additional 1,548 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD increased its position in BrightSpring Health Services by 13.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 2,698,629 shares of the company’s stock worth $45,959,000 after buying an additional 328,977 shares in the last quarter.

BrightSpring Health Services Price Performance

Shares of BrightSpring Health Services stock opened at $24.08 on Tuesday. The stock has a 50 day moving average of $21.60 and a 200 day moving average of $20.49. BrightSpring Health Services, Inc. has a 12 month low of $12.35 and a 12 month high of $25.57. The firm has a market cap of $4.27 billion, a PE ratio of 77.68 and a beta of 2.25. The company has a current ratio of 1.76, a quick ratio of 1.34 and a debt-to-equity ratio of 1.43.

BrightSpring Health Services (NASDAQ:BTSG) last posted its quarterly earnings data on Friday, August 1st. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.03. The business had revenue of $3.15 billion during the quarter, compared to analyst estimates of $2.99 billion. BrightSpring Health Services had a return on equity of 9.29% and a net margin of 0.55%.The company’s revenue for the quarter was up 15.3% on a year-over-year basis. During the same period last year, the company earned $0.10 EPS. BrightSpring Health Services has set its FY 2025 guidance at EPS. On average, research analysts expect that BrightSpring Health Services, Inc. will post 0.59 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Jon B. Rousseau sold 531,840 shares of the business’s stock in a transaction that occurred on Thursday, June 12th. The shares were sold at an average price of $21.75, for a total transaction of $11,567,520.00. Following the completion of the transaction, the insider owned 1,184,133 shares in the company, valued at $25,754,892.75. The trade was a 30.99% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, major shareholder Phoenix Aggregator L.P. Kkr sold 2,100,000 shares of the stock in a transaction dated Tuesday, June 24th. The shares were sold at an average price of $21.15, for a total value of $44,415,000.00. Following the completion of the sale, the insider owned 77,096,337 shares of the company’s stock, valued at approximately $1,630,587,527.55. This trade represents a 2.65% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,919,941 shares of company stock valued at $337,025,856 over the last three months. 3.40% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on BTSG shares. Morgan Stanley increased their target price on BrightSpring Health Services from $20.00 to $25.00 and gave the stock an “overweight” rating in a research report on Friday, May 9th. Mizuho set a $26.00 target price on BrightSpring Health Services in a research report on Monday, May 5th. Wells Fargo & Company increased their target price on BrightSpring Health Services from $25.00 to $27.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 13th. TD Cowen started coverage on BrightSpring Health Services in a research report on Monday, June 23rd. They set a “buy” rating and a $37.00 target price for the company. Finally, Wall Street Zen cut BrightSpring Health Services from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 26th. Ten research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $25.67.

BrightSpring Health Services Company Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.